Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
2017 · New England Journal of Medicine · 8,809 citations
https://doi.org/10.1056/nejmoa1707914
J
José Carlos Nicolau
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
686
Papers
45.0K
Citations
75
h-index
261
i10-index
José Carlos Nicolau is an academic researcher from Hospital São Paulo. The author has contributed to research in topics: Acute Myocardial Infarction Research & Antiplatelet Therapy and Cardiovascular Diseases & Cardiac Imaging and Diagnostics. The author has an h-index of 75, co-authored 584 publications.
ORCID: 0000-0002-9680-3689Papers by this author
worksLong-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
2015 · New England Journal of Medicine · 1,938 citations
https://doi.org/10.1056/nejmoa1500857
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
2012 · New England Journal of Medicine · 932 citations
https://doi.org/10.1056/nejmoa1200933
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
2011 · New England Journal of Medicine · 751 citations
https://doi.org/10.1056/nejmoa1109719
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
2017 · New England Journal of Medicine · 626 citations
https://doi.org/10.1056/nejmoa1701488
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
2019 · New England Journal of Medicine · 353 citations
https://doi.org/10.1056/nejmoa1908077
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat